Yan Keqin (L) and Zhang Xin take off protective suits during lunch break at China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Temporary laboratory team built up to enhance the daily nucleic acid test capacity, bolstering Beijing's fight against the epidemic.
BEIJING, July 5 (Xinhua) -- In order to timely assess COVID-19 patients for early isolation and treatment, large-scale nucleic acid testing was conducted in Beijing, putting pressure on testing institutions with the rapid rise of samples.
Local hospitals are improving their testing capacity.
After 48 hours of renovation, a new nucleic acid testing laboratory in the China-Japan Friendship Hospital started operations.
Yan Keqin and Zhang Xin, medical workers from different departments of China-Japan Friendship Hospital, now work on a temporary laboratory team to help carry out COVID-19 nucleic acid tests at the hospital. Their daily tasks include sample collection, sample disposal, virus inactivation and information input.
So far, the lab where Yan and Zhang work can handle as many as 10,000 COVID-19 tests per day.
From June 11 to July 4, Beijing reported 334 confirmed locally transmitted cases, 324 of whom were still hospitalized.
Zhang Xin arranges samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin wears a protective suit before entering a contaminated area at China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin and Zhang Xin (L) deal with samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin holds inactivated samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Zhang Xin holds inactivated samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Zhang Xin registers the serial number of samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Zhang Xin checks samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin (L) and Zhang Xin work at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin (R) and Zhang Xin deal with samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin wears protective gears before entering a contaminated area at China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin (R) and Zhang Xin thumb up at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)
Yan Keqin (L) and Zhang Xin register the information of samples for nucleic acid tests at a lab of China-Japan Friendship Hospital in Beijing, capital of China, July 3, 2020. (Xinhua/Zhang Yuwei)■
